A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

Condition:   HER2-amplified Biliary Tract Cancers Interventions:   Drug: ZW25 (Zanidatamab);   Diagnostic Test: In situ hybridization (ISH)-based companion diagnostic assay;   Diagnostic Test: Immunohistochemistry (IHC)-based companion diagnostic assay Sponsors:   Zymeworks Inc.;   BeiGene, Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials